CLEVELAND, March 17 /PRNewswire/ -- JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, and Case Technology Ventures (CTV), a pre-seed stage venture capital and technology validation fund at
(Logo: http://www.newscom.com/cgi-bin/prnh/20060209/CLJUMPSTARTLOGO )
Neuros' technology, which was created by Drs. Kevin Kilgore and Niloy Bhadra of Case Western Reserve University's Department of Biomedical Engineering and MetroHealth Medical Center, in partnership with the Cleveland FES (Functional Electrical Stimulation) Center, is referred to as "Nerve Block" and delivers high-frequency stimulation to sensory nerves in the peripheral nervous system to block chronic pain. The system consists of an electrode (also known as a lead) placed around a peripheral nerve and powered by a pace-maker size generator that is implanted into the chest cavity, abdomen, or lower leg. Because the generator operates in a much higher frequency range than conventional neurostimulation devices, Neuros' technology is able to stop nerve activity to block pain completely, as opposed to simply masking the pain signal. Case has secured a patent for this unique high-frequency application and has an additional 2 patents pending.
The company's initial target market is patients with chronic pain, specifically residual limb pain,
'/>"/>
| SOURCE JumpStart Inc. Copyright©2009 PR Newswire. All rights reserved |